Olmesartan HCTZ 20 12.5 Recall: What You Need to Know
Hello, guys! Today, we're diving into a crucial topic that might affect your health or someone you know. We're talking about the Olmesartan HCTZ 20 12.5 recall. So, buckle up as we explore what this recall is all about, why it's happening, and what you should do if you're affected. Guys, explore more in Guides And Explainers and olmesartan hctz 20 12.5 recall.
What is Olmesartan HCTZ 20 12.5?
Before we get into the nitty-gritty of the recall, let's ensure we're all on the same page. Olmesartan HCTZ 20 12.5 is a prescription medication used to treat high blood pressure (hypertension). It's a combination of two drugs: Olmesartan (the active ingredient) and Hydrochlorothiazide (a diuretic). The '20' and '12.5' refer to the strength of each component in the medication.
Why is Olmesartan HCTZ 20 12.5 Being Recalled?
Alright, let's get to the heart of the matter. The Olmesartan HCTZ 20 12.5 recall is due to the detection of a nitrosamine impurity called N-nitroso-N-methyl-4-aminobutyric acid (NMBA). Now, don't worry if that's a mouthful – we'll break it down.
Nitrosamines are a type of chemical that can form during the manufacturing process of certain drugs. The issue is that some nitrosamines have been linked to an increased risk of cancer in humans. The U.S. Food and Drug Administration (FDA) has set acceptable daily intake limits for these impurities, and the levels found in the recalled Olmesartan HCTZ 20 12.5 exceed these limits.
Which Products Are Affected?
The recall affects specific lots of Olmesartan HCTZ 20 12.5 tablets manufactured by Camber Pharmaceuticals, Inc. and marketed by Amneal Pharmaceuticals LLC. Here are the affected products:
- Olmesartan HCTZ Tablets, USP, 20 mg/12.5 mg - NDC 60522-0997-01, 90-count bottles - NDC 60522-0997-03, 500-count bottles
You can find the complete list of affected lots on the FDA's website. If you're unsure whether your medication is affected, don't hesitate to reach out to your doctor or pharmacist for clarification.
What Should You Do If You Have an Affected Product?
First and foremost, do not stop taking your medication without first consulting your healthcare provider. Abruptly stopping a blood pressure medication can be dangerous. Instead, follow these steps:
- 1. Check if your medication is affected by comparing the NDC number and lot number on your bottle with the FDA's list.
- 2. Contact your doctor or pharmacist if you find that your medication is affected. They can help you determine the best course of action, which may involve switching to a different medication.
- 3. Return the affected medication to your pharmacy for a refund. Do not throw it away.
What About Other Strengths of Olmesartan HCTZ?
As of now, only the Olmesartan HCTZ 20 12.5 recall has been announced. Other strengths of Olmesartan HCTZ, as well as other brands or manufacturers, are not affected. However, it's always a good idea to stay informed about any updates or recalls that may affect your medication.
Staying Informed About Medication Recalls
Recalls happen, and it's essential to stay informed about them. Here are a few tips to help you stay in the loop:
- Sign up for recall alerts from the FDA. You can do this on their website. - Check the FDA's recall list regularly. They update it frequently with new recalls. - Stay in touch with your doctor and pharmacist. They can provide personalized advice and guidance.
Conclusion
The Olmesartan HCTZ 20 12.5 recall is a serious matter, but it's important to stay calm and informed. By understanding the recall and following the appropriate steps, you can ensure that you or your loved ones remain safe and healthy. Always remember, if you have any questions or concerns about your medication, don't hesitate to reach out to your healthcare provider.
Thanks for joining us today, folks! We hope this article has provided you with the information you need to stay safe and healthy. Until next time, stay informed!